CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation

1.0k indexed citations

Abstract

loading...

About

This paper, published in 2003, received 1.0k indexed citations. Written by Matthias Edinger, Petra Hoffmann, Joerg Ermann, C. Garrison Fathman, Samuel Strober and Robert S. Negrin covering the research area of Immunology and Hematology. It is primarily cited by scholars working on Immunology (852 citations), Hematology (595 citations) and Oncology (208 citations). Published in Nature Medicine.

In The Last Decade

doi.org/10.1038/nm915 →

Countries where authors are citing CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation

Specialization
Citations

This map shows the geographic impact of CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation more than expected).

Fields of papers citing CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation

Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

This paper is also available at doi.org/10.1038/nm915.

Explore hit-papers with similar magnitude of impact

Rankless by CCL
2026